Remote Monitoring and Virtual Collaborative Care For Hypertension Control to Prevent Cognitive Decline Phase II
Running, not enrolling · Not applicable
Conditions studied: Hypertension
In brief
This is a randomized, controlled, pragmatic trial designed as a "type I hybrid effectiveness-implementation trial" that tests a hypertension program integrating a virtual Collaborative Care Clinic (vCCC), home blood pressure monitoring, and telehealth for lowering blood pressure (BP) in two health systems.
Key facts
- Study ID
- NCT05138601
- Run by
- University of Kansas Medical Center
- People needed
- 1000
- Starts
- 2021-11-16
- Expected to finish
- 2027-07-31
- Last updated by the study team
- 2026-06-26
Who can join
Age: 65 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 65 and older
- Active patient in participating primary care clinic
- Access to compatible "smartphone" or device (i.e., Android, Kindle or Apple with internet connectivity or mobile network)
- Elevated BP as defined by
- SBP >140 at current visit AND documented history of hypertension OR SBP > 140 at current visit and at another visit in last 18 months OR SBP >160 at current visit
- Sufficiently fluent in English to participate in study procedures
- Adequate hearing to complete study procedures
- Able to give their own signed consent
- Health insurance coverage by Medicare
You may not qualify if…
- Clinically significant illness that may affect safety or completion per their treating PCP or study physician
- Needing interpreter for clinic visits (through Electronic Health Record)
- Currently in hospice care
- Currently receiving chemotherapy
- Unable to take accurate BP measurement, either due to inability to follow protocol to check BP or due to medical conditions such as lymphedema or dialysis access on both arms.
- Currently participating in another intervention trial
- End stage kidney disease on dialysis
- Diagnosis of dementia (i.e., dementia, Alzheimer's disease, vascular dementia, dementia with Lewy bodies, frontotemporal dementia)
- Chronic active disease with expected life expectancy < 2 years as determined by the study team
Where it is running
- University of Kansas Health System — Kansas City, Kansas, United States
- University of Utah — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.